Impact of Tixel Treatment on Symptoms and Signs in Patients With Dry Eye Disease
ConditionDry Eye Disease (DED)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAston University
About this trial
This study will examine how a standard Tixel treatment versus a sham treatment for eye wrinkles affects the symptoms and signs of Dry Eye Disease.
Eligibility criteria
Qualifiers
Mild to Moderate Periorbital wrinkles
OSDI score of at least 23
Noninvasive Tear film break up time (NIBUT) ≤ 10 seconds
No other eye or skin or immune problems
Disqualifiers
Pregnancy and/or breastfeeding
Lesions in the periorbital area
Acute severe blepharitis
Acute conjunctivitis
Trial design
Treatments tested in this trial
- Thermo-mechanical action based peri-orbital fractional skin treatment
- Sham treatment
Treatment groups
36 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov